A new class of antimalarial drug has been discovered, using spiroindolones to block a pump within the malaria parasites face, causing it to fill will salt and die.
Finding vulnerabilities within the parasites physiology will allow researchers to develop new antimalarial drugs.
Read more at Australian National University